Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morsanutto, A.
Right arrow Articles by Mantovani, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morsanutto, A.
Right arrow Articles by Mantovani, L. G.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 27:1841-1842, 2004
© 2004 by the American Diabetes Association, Inc.

Letters: Observations

Major Diabetes Complications Have an Impact on Total Annual Medical Cost of Type 2 Diabetes

Andrea Morsanutto, PHARMD1, Patrizia Berto, PHARMD, MBA2, Stefania Lopatriello, PHARMD2, Dario Voinovich, PHD3, Renzo Gelisio, MD4 and Lorenzo G. Mantovani, MSC, DSC1

1 Center of Pharmacoeconomics, Department of Pharmacological Sciences, University of Milan, Milan, Italy
2 PBE Consulting, Verona, Italy
3 Department of Pharmacological Sciences, University of Trieste, Trieste, Italy
4 Diabetologic Center, ULSS 10 Portogruarese, Portogruaro, Italy

Address correspondence to Dr. Lorenzo G. Mantovani, Center of Pharmacoeconomics, Department of Pharmacological Sciences, University of Milan, Via Balzaretti, 9 I-20133 Milan, Italy. E-mail: lorenzo.mantovani@unimi.it

The first 20% of the full text of this article appears below.

Brandle et al. (1) found that the occurrence of diabetes-related comorbidities in type 2 diabetic patients are associated with an increase in average annual medical cost.

To investigate the medical cost attributable to type 2 diabetes, we conducted a retrospective longitudinal cost-of-care study in a diabetologic center in Italy. A priori, we estimated to validly enroll 300 type 2 diabetic patients with at least 1 year of follow-up. To this aim, we randomly selected 315 type 2 diabetic patients from a base of ~2,000 diabetic patients attending the diabetologic center of Portogruaro during the period from January 2001 to August 2002.

Cost included hospitalizations, visits, diagnostics, and pharmacological therapies and were . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.